Methods for making animal models of retinal vein occlusion
Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Mei Sun [verfasserIn] Xiao-Feng Hao [verfasserIn] Li-Ke Xie [verfasserIn] Qi Jin [verfasserIn] Shi-Hui Wang [verfasserIn] Jing Xu [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
retinal vein occlusion; experimental animal models; laser photocoagulation |
|---|
| Übergeordnetes Werk: |
In: Guoji Yanke Zazhi - Press of International Journal of Ophthalmology (IJO PRESS), 2017, 20(2020), 11, Seite 1841-1846 |
|---|---|
| Übergeordnetes Werk: |
volume:20 ; year:2020 ; number:11 ; pages:1841-1846 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.3980/j.issn.1672-5123.2020.11.01 |
|---|
| Katalog-ID: |
DOAJ038711249 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ038711249 | ||
| 003 | DE-627 | ||
| 005 | 20230308023501.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3980/j.issn.1672-5123.2020.11.01 |2 doi | |
| 035 | |a (DE-627)DOAJ038711249 | ||
| 035 | |a (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RE1-994 | |
| 100 | 0 | |a Mei Sun |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Methods for making animal models of retinal vein occlusion |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. | ||
| 650 | 4 | |a retinal vein occlusion; experimental animal models; laser photocoagulation | |
| 650 | 4 | |a retinal vein occlusion | |
| 650 | 4 | |a experimental animal models | |
| 650 | 4 | |a laser photocoagulation | |
| 653 | 0 | |a Ophthalmology | |
| 700 | 0 | |a Xiao-Feng Hao |e verfasserin |4 aut | |
| 700 | 0 | |a Li-Ke Xie |e verfasserin |4 aut | |
| 700 | 0 | |a Qi Jin |e verfasserin |4 aut | |
| 700 | 0 | |a Shi-Hui Wang |e verfasserin |4 aut | |
| 700 | 0 | |a Jing Xu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Guoji Yanke Zazhi |d Press of International Journal of Ophthalmology (IJO PRESS), 2017 |g 20(2020), 11, Seite 1841-1846 |w (DE-627)1680946854 |x 16725123 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2020 |g number:11 |g pages:1841-1846 |
| 856 | 4 | 0 | |u https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/51f091bb22694f6982149d74aa410a43 |z kostenfrei |
| 856 | 4 | 0 | |u http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_2817 | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2020 |e 11 |h 1841-1846 | ||
| author_variant |
m s ms x f h xfh l k x lkx q j qj s h w shw j x jx |
|---|---|
| matchkey_str |
article:16725123:2020----::ehdfraignmloesfeia |
| hierarchy_sort_str |
2020 |
| callnumber-subject-code |
RE |
| publishDate |
2020 |
| allfields |
10.3980/j.issn.1672-5123.2020.11.01 doi (DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 DE-627 ger DE-627 rakwb eng RE1-994 Mei Sun verfasserin aut Methods for making animal models of retinal vein occlusion 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology Xiao-Feng Hao verfasserin aut Li-Ke Xie verfasserin aut Qi Jin verfasserin aut Shi-Hui Wang verfasserin aut Jing Xu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 20(2020), 11, Seite 1841-1846 (DE-627)1680946854 16725123 nnns volume:20 year:2020 number:11 pages:1841-1846 https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 kostenfrei https://doaj.org/article/51f091bb22694f6982149d74aa410a43 kostenfrei http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 20 2020 11 1841-1846 |
| spelling |
10.3980/j.issn.1672-5123.2020.11.01 doi (DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 DE-627 ger DE-627 rakwb eng RE1-994 Mei Sun verfasserin aut Methods for making animal models of retinal vein occlusion 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology Xiao-Feng Hao verfasserin aut Li-Ke Xie verfasserin aut Qi Jin verfasserin aut Shi-Hui Wang verfasserin aut Jing Xu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 20(2020), 11, Seite 1841-1846 (DE-627)1680946854 16725123 nnns volume:20 year:2020 number:11 pages:1841-1846 https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 kostenfrei https://doaj.org/article/51f091bb22694f6982149d74aa410a43 kostenfrei http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 20 2020 11 1841-1846 |
| allfields_unstemmed |
10.3980/j.issn.1672-5123.2020.11.01 doi (DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 DE-627 ger DE-627 rakwb eng RE1-994 Mei Sun verfasserin aut Methods for making animal models of retinal vein occlusion 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology Xiao-Feng Hao verfasserin aut Li-Ke Xie verfasserin aut Qi Jin verfasserin aut Shi-Hui Wang verfasserin aut Jing Xu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 20(2020), 11, Seite 1841-1846 (DE-627)1680946854 16725123 nnns volume:20 year:2020 number:11 pages:1841-1846 https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 kostenfrei https://doaj.org/article/51f091bb22694f6982149d74aa410a43 kostenfrei http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 20 2020 11 1841-1846 |
| allfieldsGer |
10.3980/j.issn.1672-5123.2020.11.01 doi (DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 DE-627 ger DE-627 rakwb eng RE1-994 Mei Sun verfasserin aut Methods for making animal models of retinal vein occlusion 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology Xiao-Feng Hao verfasserin aut Li-Ke Xie verfasserin aut Qi Jin verfasserin aut Shi-Hui Wang verfasserin aut Jing Xu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 20(2020), 11, Seite 1841-1846 (DE-627)1680946854 16725123 nnns volume:20 year:2020 number:11 pages:1841-1846 https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 kostenfrei https://doaj.org/article/51f091bb22694f6982149d74aa410a43 kostenfrei http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 20 2020 11 1841-1846 |
| allfieldsSound |
10.3980/j.issn.1672-5123.2020.11.01 doi (DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 DE-627 ger DE-627 rakwb eng RE1-994 Mei Sun verfasserin aut Methods for making animal models of retinal vein occlusion 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology Xiao-Feng Hao verfasserin aut Li-Ke Xie verfasserin aut Qi Jin verfasserin aut Shi-Hui Wang verfasserin aut Jing Xu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 20(2020), 11, Seite 1841-1846 (DE-627)1680946854 16725123 nnns volume:20 year:2020 number:11 pages:1841-1846 https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 kostenfrei https://doaj.org/article/51f091bb22694f6982149d74aa410a43 kostenfrei http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 AR 20 2020 11 1841-1846 |
| language |
English |
| source |
In Guoji Yanke Zazhi 20(2020), 11, Seite 1841-1846 volume:20 year:2020 number:11 pages:1841-1846 |
| sourceStr |
In Guoji Yanke Zazhi 20(2020), 11, Seite 1841-1846 volume:20 year:2020 number:11 pages:1841-1846 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation Ophthalmology |
| isfreeaccess_bool |
true |
| container_title |
Guoji Yanke Zazhi |
| authorswithroles_txt_mv |
Mei Sun @@aut@@ Xiao-Feng Hao @@aut@@ Li-Ke Xie @@aut@@ Qi Jin @@aut@@ Shi-Hui Wang @@aut@@ Jing Xu @@aut@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
1680946854 |
| id |
DOAJ038711249 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ038711249</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308023501.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2020.11.01</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ038711249</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ51f091bb22694f6982149d74aa410a43</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Mei Sun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Methods for making animal models of retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinal vein occlusion; experimental animal models; laser photocoagulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">experimental animal models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xiao-Feng Hao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li-Ke Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qi Jin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shi-Hui Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jing Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">20(2020), 11, Seite 1841-1846</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1841-1846</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2020.11.01</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/51f091bb22694f6982149d74aa410a43</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2020</subfield><subfield code="e">11</subfield><subfield code="h">1841-1846</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
Mei Sun |
| spellingShingle |
Mei Sun misc RE1-994 misc retinal vein occlusion; experimental animal models; laser photocoagulation misc retinal vein occlusion misc experimental animal models misc laser photocoagulation misc Ophthalmology Methods for making animal models of retinal vein occlusion |
| authorStr |
Mei Sun |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1680946854 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RE1-994 |
| illustrated |
Not Illustrated |
| issn |
16725123 |
| topic_title |
RE1-994 Methods for making animal models of retinal vein occlusion retinal vein occlusion; experimental animal models; laser photocoagulation retinal vein occlusion experimental animal models laser photocoagulation |
| topic |
misc RE1-994 misc retinal vein occlusion; experimental animal models; laser photocoagulation misc retinal vein occlusion misc experimental animal models misc laser photocoagulation misc Ophthalmology |
| topic_unstemmed |
misc RE1-994 misc retinal vein occlusion; experimental animal models; laser photocoagulation misc retinal vein occlusion misc experimental animal models misc laser photocoagulation misc Ophthalmology |
| topic_browse |
misc RE1-994 misc retinal vein occlusion; experimental animal models; laser photocoagulation misc retinal vein occlusion misc experimental animal models misc laser photocoagulation misc Ophthalmology |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Guoji Yanke Zazhi |
| hierarchy_parent_id |
1680946854 |
| hierarchy_top_title |
Guoji Yanke Zazhi |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1680946854 |
| title |
Methods for making animal models of retinal vein occlusion |
| ctrlnum |
(DE-627)DOAJ038711249 (DE-599)DOAJ51f091bb22694f6982149d74aa410a43 |
| title_full |
Methods for making animal models of retinal vein occlusion |
| author_sort |
Mei Sun |
| journal |
Guoji Yanke Zazhi |
| journalStr |
Guoji Yanke Zazhi |
| callnumber-first-code |
R |
| lang_code |
eng |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
txt |
| container_start_page |
1841 |
| author_browse |
Mei Sun Xiao-Feng Hao Li-Ke Xie Qi Jin Shi-Hui Wang Jing Xu |
| container_volume |
20 |
| class |
RE1-994 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Mei Sun |
| doi_str_mv |
10.3980/j.issn.1672-5123.2020.11.01 |
| author2-role |
verfasserin |
| title_sort |
methods for making animal models of retinal vein occlusion |
| callnumber |
RE1-994 |
| title_auth |
Methods for making animal models of retinal vein occlusion |
| abstract |
Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. |
| abstractGer |
Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. |
| abstract_unstemmed |
Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_11 GBV_ILN_2817 |
| container_issue |
11 |
| title_short |
Methods for making animal models of retinal vein occlusion |
| url |
https://doi.org/10.3980/j.issn.1672-5123.2020.11.01 https://doaj.org/article/51f091bb22694f6982149d74aa410a43 http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf https://doaj.org/toc/1672-5123 |
| remote_bool |
true |
| author2 |
Xiao-Feng Hao Li-Ke Xie Qi Jin Shi-Hui Wang Jing Xu |
| author2Str |
Xiao-Feng Hao Li-Ke Xie Qi Jin Shi-Hui Wang Jing Xu |
| ppnlink |
1680946854 |
| callnumber-subject |
RE - Ophthalmology |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.3980/j.issn.1672-5123.2020.11.01 |
| callnumber-a |
RE1-994 |
| up_date |
2024-07-03T19:27:55.292Z |
| _version_ |
1803587289396281344 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ038711249</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308023501.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2020.11.01</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ038711249</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ51f091bb22694f6982149d74aa410a43</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Mei Sun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Methods for making animal models of retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Retinal vein occlusion(RVO)is divided into branch retinal vein occlusion and central retinal vein occlusion. It is characterized by retinal vein dilatation and tortuosity, blood flow stasis, bleeding and edema. It is often accompanied by macular edema(ME)and neovascularization. Neovascular glaucoma is the most serious complications. RVO is the second most common cause of visual loss classified under retinal vascular disorders after diabetic retinopathy. So far, the number of patients suffering from retinal vein occlusion has increased, but the pathogenesis of retinal vein occlusion has not been fully understood and there are no treatments that are very long-lasting. The research of animal models on the pathogenesis and treatment of the RVO is very important. Therefore, this article gives a briefly review to the animals and model making methods used in retinal vein occlusion experiments, and discusses the advantages and disadvantages of various RVO animal models.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinal vein occlusion; experimental animal models; laser photocoagulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">experimental animal models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xiao-Feng Hao</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Li-Ke Xie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qi Jin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Shi-Hui Wang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jing Xu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">20(2020), 11, Seite 1841-1846</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:20</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1841-1846</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2020.11.01</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/51f091bb22694f6982149d74aa410a43</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2020/11/202011001.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">20</subfield><subfield code="j">2020</subfield><subfield code="e">11</subfield><subfield code="h">1841-1846</subfield></datafield></record></collection>
|
| score |
7.39822 |